Baidu
map

2019 ACR适宜性标准:共济失调

2019-05-15 美国放射治疗及肿瘤学会 J Am Coll Radiol. 2019 May;16(5S):S44-S56.

2019年5月,美国放射学会(ACR)发布了共济失调适宜性影像学检查标准。共济失调可由小脑、脊髓、周围神经和/或前庭系统的异常引起,病理学涉及大脑,例如脑梗塞和脑积水也可以共济失调为表现。本文主要针对共济失调的适应性影像学检查评估提出指导建议。

中文标题:

2019 ACR适宜性标准:共济失调

英文标题:

ACR Appropriateness Criteria® Ataxia.

发布日期:

2019-05-15

简要介绍:

2019年5月,美国放射学会(ACR)发布了共济失调适宜性影像学检查标准。共济失调可由小脑、脊髓、周围神经和/或前庭系统的异常引起,病理学涉及大脑,例如脑梗塞和脑积水也可以共济失调为表现。本文主要针对共济失调的适应性影像学检查评估提出指导建议。 

拓展指南:共济失调相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ACR适宜性标准:共济失调)] GetToolGuiderByIdResponse(projectId=1, id=669df1c001ea89b2, title=2019 ACR适宜性标准:共济失调, enTitle=ACR Appropriateness Criteria® Ataxia., guiderFrom=J Am Coll Radiol. 2019 May;16(5S):S44-S56., authorId=null, author=, summary=2019年5月,美国放射学会(ACR)发布了共济失调适宜性影像学检查标准。共济失调可由小脑、脊髓、周围神经和/或前庭系统的异常引起,病理学涉及大脑,例如脑梗塞和脑积水也可以共济失调为表现。本文主要针对共济失调的适应性影像学检查评估提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=9, associationName=美国放射治疗及肿瘤学会, associationIntro=美国放射治疗及肿瘤学会(ASTRO,American Society for Therapeutic Radiology Oncology)成立于1958年,其使命是:通过促进优质的患者监护推进放射肿瘤学的实践,为教育和专业发展提供机会,促进研究、传播研究结果并在快速发展的卫生保健环境中代表着放射肿瘤学。成立至今,ASTRO已拥有1万多名会员,包括放射肿瘤医师、放射肿瘤学护士、医用物理学家、放射治疗学家、剂量测定员和生物学家等等,是全球最大的放射肿瘤学组织之一。, copyright=0, guiderPublishedTime=Wed May 15 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年5月,美国放射学会(ACR)发布了共济失调适宜性影像学检查标准。共济失调可由小脑、脊髓、周围神经和/或前庭系统的异常引起,病理学涉及大脑,例如脑梗塞和脑积水也可以共济失调为表现。本文主要针对共济失调的适应性影像学检查评估提出指导建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>共济失调</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=ff7851c001581030" title="2018 共识文章:共济失调神经电生理评估日常实践" target=_blank>2018 共识文章:共济失调神经电生理评估日常实践</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=1aa1f1c0013e669e" title="2010 EMQN 脊髓小脑共济失调分子遗传学诊断最佳实践指南" target=_blank>2010 EMQN 脊髓小脑共济失调分子遗传学诊断最佳实践指南</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=836431c0011e6593" title="2015遗传性共济失调诊断与治疗专家共识" target=_blank>2015遗传性共济失调诊断与治疗专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=840ee1c0010a09b8" title="2014 EFNS/ENS成人慢性共济失调的诊断和管理建议" target=_blank>2014 EFNS/ENS成人慢性共济失调的诊断和管理建议</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E5%85%B1%E6%B5%8E%E5%A4%B1%E8%B0%83" target=_blank>有关共济失调更多指南</a></ul>, tagList=[TagDto(tagId=11222, tagName=共济失调)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5389, appHits=180, showAppHits=0, pcHits=3293, showPcHits=2908, likes=94, shares=1, comments=3, approvalStatus=1, publishedTime=Sun Jun 16 23:48:03 CST 2019, publishedTimeString=2019-05-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jun 16 23:48:03 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 21:03:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ACR适宜性标准:共济失调)])
2019 ACR适宜性标准:共济失调
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1071706, encodeId=205f10e17061c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbb55483145, createdName=charly, createdTime=Fri Nov 19 10:43:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898957, encodeId=c1df89895ebc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210115/140fbe6accd7480ea0e3434f5e1ba8a4/e43e7f89790f41b281c4126974e663e2.jpg, createdBy=21b05426797, createdName=ms7000001472296566, createdTime=Fri Nov 13 15:53:29 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898956, encodeId=a767898956c5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210115/140fbe6accd7480ea0e3434f5e1ba8a4/e43e7f89790f41b281c4126974e663e2.jpg, createdBy=21b05426797, createdName=ms7000001472296566, createdTime=Fri Nov 13 15:53:19 CST 2020, time=2020-11-13, status=1, ipAttribution=)]
    2021-11-19 charly

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1071706, encodeId=205f10e17061c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbb55483145, createdName=charly, createdTime=Fri Nov 19 10:43:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898957, encodeId=c1df89895ebc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210115/140fbe6accd7480ea0e3434f5e1ba8a4/e43e7f89790f41b281c4126974e663e2.jpg, createdBy=21b05426797, createdName=ms7000001472296566, createdTime=Fri Nov 13 15:53:29 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898956, encodeId=a767898956c5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210115/140fbe6accd7480ea0e3434f5e1ba8a4/e43e7f89790f41b281c4126974e663e2.jpg, createdBy=21b05426797, createdName=ms7000001472296566, createdTime=Fri Nov 13 15:53:19 CST 2020, time=2020-11-13, status=1, ipAttribution=)]
    2020-11-13 ms7000001472296566

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1071706, encodeId=205f10e17061c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbb55483145, createdName=charly, createdTime=Fri Nov 19 10:43:55 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898957, encodeId=c1df89895ebc, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210115/140fbe6accd7480ea0e3434f5e1ba8a4/e43e7f89790f41b281c4126974e663e2.jpg, createdBy=21b05426797, createdName=ms7000001472296566, createdTime=Fri Nov 13 15:53:29 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898956, encodeId=a767898956c5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210115/140fbe6accd7480ea0e3434f5e1ba8a4/e43e7f89790f41b281c4126974e663e2.jpg, createdBy=21b05426797, createdName=ms7000001472296566, createdTime=Fri Nov 13 15:53:19 CST 2020, time=2020-11-13, status=1, ipAttribution=)]
    2020-11-13 ms7000001472296566

    0

Baidu
map
Baidu
map
Baidu
map